Keeping Track: Submissions Galore, And Still More 'Breakthroughs'
The latest drug development news and highlights from our FDA Performance Tracker.
You may also be interested in...
Building on research by Dana-Farber professor Wayne Marasco, the partners are backing a bispecific approach to CAR-Ts in solid tumors. Seelos licenses a Parkinson’s gene therapy candidate from Duke.
Keeping Track: New MCL Treatment Calquence, Submissions Galore, And A Breakthrough Designation For GSK
The latest drug development news and highlights from our US FDA Performance Tracker.
FDA is conducting additional inspections of the site of a hypersensitivity study the agency requested in 2008; concerns about the study derailed a committee review in 2013.